# 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis

> **NCT03232580** · PHASE2 · TERMINATED · sponsor: **Advanced Accelerator Applications** · enrollment: 5 (actual)

## Conditions studied

- Spondyloarthritis

## Interventions

- **DRUG:** rhAnnexin V-128

## Key facts

- **NCT ID:** NCT03232580
- **Lead sponsor:** Advanced Accelerator Applications
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-18
- **Primary completion:** 2018-11-12
- **Final completion:** 2018-11-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Sponsor Decision based on strategic considerations.
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232580, "99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03232580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*